April 20, 2014 4:58 PM ET

Biotechnology

Company Overview of Agouron Pharmaceuticals, Inc.

Company Overview

Agouron Pharmaceuticals, Inc.’s operations consists of the discovery, development, manufacture, and marketing of therapeutic products engineered to inactivate proteins, which play roles in cancer, AIDS, and other serious diseases. Its product, VIRACEPT®, was a drug for the treatment of HIV infection. Agouron Pharmaceuticals, Inc. operates as a subsidiary of Pfizer Inc.

10350 North Torrey Pines Road

Suite 100

La Jolla, CA 92037

United States

991 Employees

Phone:

619-622-3000

Key Executives for Agouron Pharmaceuticals, Inc.

Chief Executive Officer
Age: 67
Chief Financial Officer and Corporate Vice President of Finance
Age: 64
Corporate Vice President of Operations
Age: 70
Vice President and president of Alanex
Age: 66
Vice President
Age: 66
Compensation as of Fiscal Year 2013.

Similar Private Companies By Industry

Company Name Region
Incumed, Inc. United States
Emiliem, Inc. United States
Edimer Pharmaceuticals Inc. United States
ZyStor Therapeutics, Inc. United States
Calando Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Agouron Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.